FDA approves first oral tablet for alopecia treatment (WTOP)

June 15, 2022

The Food and Drug Administration approved Olumiant, a drug that restores hair growth and can act as a treatment for alopecia Monday.

Alopecia is an autoimmune disorder in which the immune system attacks hair follicles, resulting in hair loss on the scalp and, in some cases, the rest of the body.

This is the first systemic treatment for the disorder, which affects hundreds of thousands of people every year, said Dr. Adam Friedman, professor and chair of dermatology at The George Washington University School of Medicine and Health Sciences.

“This is extraordinary,” Friedman said. “Up until now, we’ve been using many different medications, all of which are not approved and being used off-label to manage this condition. But, we had nothing else.”

 

Read the full article on WTOP.com

Latest News

September 15, 2022
Stork bites and angel’s kiss sound poetic, but they actually describe vascular birthmarks, skin changes that commonly appear at or shortly after birth. These marks may change over time, so it’s important to get a dermatologist’s opinion from day one.
September 15, 2022
The GW Medical Faculty Associates (GW MFA) is pleased to welcome Meghan M. Smith, MBA, as the Executive Director of Practice Operations in the Department of Medicine. In this role, Smith will work with executive, clinical, and physician leadership to develop and implement strategies, manage key…
September 15, 2022
The GW Medical Faculty Associates (GW MFA) welcomes Hitan Kamdar, MBA, MS, as executive director of patient access. Kamdar will be responsible for optimizing patient access to ambulatory care at the GW MFA. In this role, he will oversee call operations, the Unified Contact Center, provider capacity…